Browse All

Current Filters

CLEAR FILTER x

TITLE

Title
    Author Last Name
      Session Name
        Topic
          Program Number
            Author Institution

              Gender, Race, and Socioeconomic Disparities on Surgical Device-aided Therapies (DATs) Among Medicare Beneficiaries with Advanced Parkinson’s Disease (aPD)

              Author:Jimenez Shahed, Joohi   Malaty, Irene   Soileau, Michael   Baldwin, Zach   Yan, Connie   Kandukuri, Lakshmi   Schinkel, Jill   Teigland, Christie   Pulungan, Zulkarnain   Shah, Megha   Kukreja, Pavnit   Hambrick, Aaron   Shewale, Anand   Fernandez, Hubert   

              Session Name:S2: Movement Disorders: Epidemiology and Clinical Aspects  

              Topic:Movement Disorders  

              Program Number:S2.007  

              Author Institution:Icahn School of Medicine at Mount Sinai, New York City, NY  University of Florida, Gainesville, FL  Texas Movement Disorder Specialists, PLLC, Georgetown, TX  AbbVie Inc., Mettawa, IL  AbbVie Inc., North Chicago, IL  Inovalon Insights, Bowie, MD  Inovalon Insights, Washington, DC  AbbVie Inc., Detroit, MI  AbbVie Inc., Irvine, CA  Center for Neurological Restoration, Cleveland Clinic, Cleveland, OH  

              Improvement of “On” and “Off” Times in Patients with Advanced Parkinson’s Disease Treated with Foslevodopa/Foscarbidopa: Subgroup Analyses from a Phase 3 Randomized Study

              Author:Kern, Drew   Hauser, Robert   Kimber, Thomas   Vaou, Okeanis   Bergmann, Lars   Gupta, Resmi   Jeong, Anna   Jia, Jia   Shah, Megha   Soileau, Michael   

              Session Name:S30: Movement Disorders: Clinical Trials in Movement Disorders  

              Topic:Movement Disorders  

              Program Number:S30.007  

              Author Institution:University of Colorado Anschutz Medical Campus, Aurora, CO  University of South Florida Parkinson’s Disease and Movement Disorders Center of Excellence, Tampa, FL  Royal Adelaide Hospital, Beulah Park, Australia  St. Elizabeth’s Medical Center, Brighton, MA  AbbVie Inc., North Chicago, IL  Texas Movement Disorder Specialists, Georgetown, TX  

              Effectiveness and Satisfaction with Deutetrabenazine in Huntington Disease When Initiated Using a 4-week Patient Titration Kit: Final Results of the START Study

              Author:Anderson, Karen   Konings, Martijn   Finkbeiner, Stacy   Bennett, James   Soileau, Michael   Cutler, Andrew   

              Session Name:P8: Movement Disorders: Huntington's and Other Choreas 2  

              Topic:Movement Disorders  

              Program Number:P8.008  

              Author Institution:Georgetown University, Bethesda, MD  Teva Branded Pharmaceutical Products R&D, Inc., West Chester, PA  Teva Branded Pharmaceutical Products R&D, Inc., Parsippany, NJ  Texas Movement Disorder Specialists, PLLC, Georgetown, TX  SUNY Upstate Medical University, Lakewood Ranch, FL  

              Living with Continuous Subcutaneous Infusion of Foslevodopa/Foscarbidopa for Symptom Management in Advanced Parkinson’s Disease: A Patient Experience Study

              Author:Soileau, Michael   Aldred, Jason   Baldwin, Zach   Yan, Connie   Brion, Triza   Bellenger, Alex   Suh, JeeHee   Shah, Megha   Kukreja, Pavnit   Facheris, Maurizio   Shewale, Anand   Kumar, Rajeev   

              Session Name:P9: Movement Disorders: Parkinson's Disease Clinical Trials  

              Topic:Movement Disorders  

              Program Number:P9.006  

              Author Institution:Texas Movement Disorder Specialists, PLLC, Georgetown, TX  Selkirk Neurology, Spokane, WA  AbbVie Inc., Mettawa, IL  AbbVie Inc., North Chicago, IL  ICON Plc, Raleigh, NC  AbbVie Inc., Detroit, MI  AbbVie Inc., Irvine, CA  Rocky Mountain Movement Disorders Center, Englewood, CO